UK Markets closed
  • NIKKEI 225

    27,433.40
    +50.84 (+0.19%)
     
  • HANG SENG

    22,069.73
    -619.17 (-2.73%)
     
  • CRUDE OIL

    77.81
    -1.87 (-2.35%)
     
  • GOLD FUTURES

    1,939.00
    -6.60 (-0.34%)
     
  • DOW

    33,717.09
    -260.99 (-0.77%)
     
  • BTC-GBP

    18,385.89
    -956.62 (-4.95%)
     
  • CMC Crypto 200

    514.97
    -22.91 (-4.26%)
     
  • ^IXIC

    11,393.81
    -227.90 (-1.96%)
     
  • ^FTAS

    4,265.16
    +6.19 (+0.15%)
     

Biodefence Market Report 2023-2033

ReportLinker
ReportLinker

Forecasts by Product (Vaccines (Anthrax, Smallpox, Botulism), Biothreat Detection Devices (Assays and Reagents, Detectors, Identifiers, Samplers)) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biodefence Market Report 2023-2033" - https://www.reportlinker.com/p06383482/?utm_source=GNW

The Biodefence Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing RandD Investments in Developed Countries

Growing RandD investments enable pharmaceutical and biopharmaceutical companies to manufacture superior quality and technologically advanced bio-threat detection devices that should significantly impact the industry growth. Furthermore, European government also supports the RandD activities to manufacture vaccines against various diseases such as anthrax, small pox and botulism in large batches to fight infections and prevent the spread of endemic diseases. Bioterrorism attacks lead to deaths and may weaken the economy hence, government funds various pharmaceutical as well as biopharmaceutical companies that will elevate the industry growth in foreseeable future.

Increasing Awareness Regarding Bioterrorism Attacks to Propel Industry Growth

Increasing awareness regarding bioterrorism attacks in developed as well as underdeveloped economies will significantly fuel the biodefence market growth over the forecast period. Owing to the advent of internet and growing adoption of social media, news about the biological warfare in any part of the world can spread across the globe. It can cause anxiety to people located faraway and can greatly impact trade and travel. Governments in the developing countries such as Japan and India plan public awareness campaigns to raise public awareness about bioterrorism attacks. Such preventive measures undertaken by the government to combat various endemic diseases will boost industry growth in the foreseeable future.

Low Government Funding in Underdeveloped Regions Likely to Challenge Market Growth

Minimal government intervention and low RandD funding in underdeveloped regions will impede the biodefence market growth over the forecast period. Furthermore, due to poor economic development, governments and regulatory authorities in countries such as Mexico and Brazil are unable to make significant investments to promote the use of biothreat detection devices. There is a lack of awareness in developing regions about the availability of technologically advanced biothreat detection devices. Additionally, there is no established regulatory framework for biodefence devices and vaccines in underdeveloped economies. Key players that operate in the biodefence industry find it difficult to enter these countries due to changing trade policies. As a result, the distribution of tools and vaccinations used to combat bioterrorism is low in emerging regions which may hamper the Biodefence market growth.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Biodefence Market evolving?

• What is driving and restraining the Biodefence Market?

• How will each Biodefence submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each Biodefence submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading Biodefence Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the Biodefence development projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of Biodefence development projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the Biodefence Market?

• Where is the Biodefence Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biodefence Market today, and over the next 10 years:

• Our 197-page report provides 112 tables and 107 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Biodefence Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of bio-threat detection devices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product

• Vaccines

- Anthrax

- Small Pox

- Botulism

- Others

• Biothreat detection devices

- Assays and reagents

- Detectors

- Identifiers

- Samplers

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

• U.S.

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific

Latin America

• Brazil

• Mexico

• Rest of Latin America

MEA

• GCC

• South Africa

• Rest of MEA

The report also includes profiles and for some of the leading companies in the Biodefence Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Alexeter Technologies, LLC,

• Altimmune

• Achaogen, Inc.

• Alnylam Pharmaceuticals

• ANP Technology

• Bavarian Nordic

• BBI Detection

• Biofire Defense (bioMerieux SA)

• Biosearch Technologies

• Bruker

• Dynport Vaccine Company

• Electronic Sensor Technology Inc.

• Elusys Therapeutics

• Emergent BioSolutions Inc.

• Ichor Medical

• NanoLogix

• New Horizons Diagnostic Corporation

• PositiveID Corporation

• Research International

• SIGA Technologies, Inc.

• Statera Biopharma (Cleveland Biolabs)

• Smith’s Detection

• Synexis Systems

Overall world revenue for Biodefence Market, 2023 to 2033 in terms of value the market will surpass US$15,922 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biodefence Market, 2023 to 2033 report help you?

In summary, our 197-page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Biodefence Market, 2023 to 2033 Market, with forecasts for Type of Product, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Biodefence Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Biodefence Market, 2023 to 2033.


Read the full report: https://www.reportlinker.com/p06383482/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001